BRAF and nevus: The AUROCMLP6 of the model was 0.79 (95% CІ: 0.74–0.84), which reflects the good consistency of the BRAF mutation risk prediction model using 6 variables, such as age, primary tumor location, histological type, ulceration, LVI, and association with a nevus (Figure 1).